We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-4.37%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$586B
AUM Growth
-$76.8B
Cap. Flow
-$2B
Cap. Flow %
-0.34%
Top 10 Hldgs %
27.57%
Holding
13,842
New
1,775
Increased
5,712
Reduced
4,842
Closed
1,482

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.1%
2 Technology 1.55%
3 Consumer Discretionary 0.95%
4 Financials 0.77%
5 Healthcare 0.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLYA
10776
PUT
DELISTED
Playa Hotels & Resorts
PLYA
$217K ﹤0.01%
+16,300
New +$212K
HI
10777
PUT
DELISTED
Hillenbrand
HI
$217K ﹤0.01%
+9,000
New +$274K
ADPT icon
10778
PUT
Adaptive Biotechnologies
ADPT
$4.02B
$217K ﹤0.01%
29,200
+10,500
+56% +$80.7K
CCSI icon
10779
PUT
Consensus Cloud Solutions
CCSI
$696M
$217K ﹤0.01%
+9,400
New +$242K
TFII icon
10780
CALL
TFI International
TFII
$11B
$217K ﹤0.01%
2,800
-4,200
-60% -$465K
TK icon
10781
CALL
Teekay
TK
$1.14B
$217K ﹤0.01%
33,000
-80,000
-71% -$553K
ITOS
10782
DELISTED
iTeos Therapeutics
ITOS
$217K ﹤0.01%
36,308
-197,568
-84% -$1.45M
GOCO
10783
DELISTED
GoHealth
GOCO
$216K ﹤0.01%
+17,632
New +$269K
BUYZ icon
10784
Franklin Disruptive Commerce ETF
BUYZ
$5.56M
$216K ﹤0.01%
6,309
-480
-7% -$18K
UNL icon
10785
CALL
United States 12 Month Natural Gas Fund
UNL
$15.9M
$216K ﹤0.01%
+21,100
New +$199K
PTVE
10786
PUT
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$216K ﹤0.01%
+12,000
New +$213K
JANH icon
10787
Innovator Premium Income 20 Barrier ETF January
JANH
$13.8M
$216K ﹤0.01%
+8,899
New +$220K
PBYI icon
10788
Puma Biotechnology
PBYI
$468M
$216K ﹤0.01%
72,871
-2,232
-3% -$6.99K
IYM icon
10789
CALL
iShares US Basic Materials ETF
IYM
$1.03B
$216K ﹤0.01%
+1,600
New +$218K
SCPH
10790
CALL
DELISTED
scPharmaceuticals
SCPH
$216K ﹤0.01%
82,000
-18,400
-18% -$59.9K
NBB icon
10791
Nuveen Taxable Municipal Income Fund
NBB
$454M
$215K ﹤0.01%
+13,449
New +$213K
LLYX
10792
Defiance Daily Target 2x Long LLY ETF
LLYX
$42.6M
$215K ﹤0.01%
+10,967
New +$225K
HOMZ icon
10793
Hoya Capital Housing ETF
HOMZ
$35.2M
$215K ﹤0.01%
+4,819
New +$220K
ACHV icon
10794
Achieve Life Sciences
ACHV
$834M
$215K ﹤0.01%
80,675
+58,141
+258% +$181K
KWT icon
10795
iShares MSCI Kuwait ETF
KWT
$67.9M
$215K ﹤0.01%
6,034
-36,670
-86% -$1.27M
SCHP icon
10796
CALL
Schwab US TIPS ETF
SCHP
$16.5B
$215K ﹤0.01%
8,000
-97,100
-92% -$2.55M
SHY icon
10797
PUT
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$215K ﹤0.01%
+2,600
New +$214K
EML icon
10798
Eastern Company
EML
$158M
$215K ﹤0.01%
+8,477
New +$230K
NKTR icon
10799
CALL
Nektar Therapeutics
NKTR
$2.48B
$215K ﹤0.01%
21,033
+18,473
+722% +$241K
ORMP icon
10800
Oramed Pharmaceuticals
ORMP
$209M
$214K ﹤0.01%
100,196
+9,169
+10% +$21.2K

Similar funds

Jeff Yass's Q1 2025 Portfolio in Review

As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
  • Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
  • Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
  • Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
  • Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
  • Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.